Sen. Kennedy’s Foreign Inspection Bill Gives FDA More Flexibility Than House

House and Senate Democrats are taking similar approaches in regard to invigorating FDA's ability to oversee foreign manufacturing facilities. But some fundamental differences and Republican concerns suggest that the issue will likely not be resolved until at least the next Congress